<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Q318 OrthoBio Market Recap: Acquisitions and Partnerships Rule

Posted by Kim French on 12/14/18 2:28 PM

Q318 OrthoBio RecapAcquisitions and Partnerships are Highpoints in Q318

SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...

Among the many topics covered in the Q318 OrthoBio Market Recap are:

  • Market Overview
  • Market Dynamics Continue to Shape the Bone Replacement Segment
  • US Stem Cells Segment
  • US Bone Growth Factors Segment
  • US Synthetics Segment
  • US DBM Segment
  • US Spinal Constructs
  • Strong Performance for US Cartilage Replacement Market
  • US Soft Tissue Replacement Segment Softens Slightly
  • Challenges Continue for Meniscal Allografts
  • Regulatory Approval Highlights Q318

Competition within in the market is propelling companies to be more strategic, leading to partnerships, acquisitions, divestitures and increased investments in product development and commercialization...

Read the entire Q318 US OrthoBio Market Recap including news, data and analysis*...

*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

Topics: OrthoBio, Q318 Market Recaps

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts